Performance Support
Performance Support Discussion Protocol
Educational protocol for athletic performance and conditioning compound discussions
• This protocol is provided for educational and informational purposes only. It does not constitute medical advice, a diagnosis, a treatment plan, or a prescription.
• All dose ranges, frequencies, durations, and compound selections must be determined by a licensed healthcare professional based on your individual medical history, lab results, and clinical assessment.
• Lab monitoring may be required depending on the compound(s), individual health status, and duration of use. Discuss appropriate monitoring protocols with your clinician.
• Do not use any peptide compound if you are pregnant, breastfeeding, a minor, or have uncontrolled medical conditions without explicit direction from your physician.
Very High Risk — Research Context Only
Research-context only; extensive supervision and monitoring required
Overview
This VERY HIGH RISK protocol covers compounds studied for effects on muscle physiology and performance. Many compounds in this category have extremely limited human safety data and require extensive specialist oversight. This protocol is for research review only.
Mechanism Summary
Compounds in this category explore myostatin/ActRIIB pathway modulation, which regulates muscle mass and composition. Research applications include muscular dystrophy and other wasting diseases. Performance applications in healthy individuals are largely experimental with unknown risk profiles.
Intended Goal
Prepare for a clinician discussion on performance-related peptide research
Follistatin 344
Myostatin inhibition / muscle mass research
Research compound studied for muscle-mass modulation. Very limited human data. Catalog reference only.
ACE-031
Myostatin pathway / muscle disease research
Studied in neuromuscular disease contexts. Experimental. Catalog reference only.
Research reference values only. Confirm all parameters with current literature and your clinician.
Who may be a candidate
- ✓Clinical researchers studying myostatin pathway interventions
- ✓Individuals with clinician-diagnosed muscle-wasting diseases under specialist care
- ✓Not appropriate for healthy individuals seeking performance enhancement
Exclusions
- ✕Not appropriate for healthy performance enhancement
- ✕Not suitable without specialist sports medicine or endocrinology evaluation
- ✕Not intended for competitive athletes — regulatory status with sports organizations must be verified
Do I have a clinically recognized condition that would justify exploring this compound?
What cardiovascular monitoring would be required?
Is this compound prohibited by relevant sports organizations?
What are the current published safety findings in human subjects?
Print or copy these questions using the "Copy Summary" button to bring to your appointment.
Legal & Compliance Notice
Many performance-enhancing research compounds are prohibited by WADA and anti-doping organizations. Legal therapeutic use requires specific clinical indications. Verify with qualified legal and medical counsel.
The legal and regulatory status of research compounds varies by country and jurisdiction. It is the user's responsibility to understand applicable local laws before engaging with any compound.
This application does not provide personalized dosing recommendations. Users who require medical guidance should consult a qualified clinician.
Last reviewed: 2025-01-15 · Status: reviewed
Discuss with Your Clinician
Use this protocol as a research starting point. A qualified healthcare professional can review your health history, order appropriate labs, and help you determine what approach — if any — makes sense for your specific situation.